| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 09/13/2001 | CA2402179A1 Tricyclic dihydropyrazolone and tricyclic dihydroisoxazolone potassium channel openers |
| 09/13/2001 | CA2401541A1 Human protein kinases and protein kinase-like enzymes |
| 09/13/2001 | CA2401524A1 New ccr5 modulators: benzimidazoles or benzotriazoles |
| 09/13/2001 | CA2401454A1 G-protein coupled receptors |
| 09/13/2001 | CA2401398A1 Dna encoding human acid-sensing ion channel bnac4 (asic4) |
| 09/13/2001 | CA2401323A1 Treatment of diseases associated with cytokine production with inhibitors of the tec family of protein tyrosine kinases |
| 09/13/2001 | CA2400571A1 Treatment of psoriasis |
| 09/13/2001 | CA2399921A1 Protein tyrosine phosphatase polynucleotides, polypeptides, and antibodies |
| 09/13/2001 | CA2372931A1 Oleoresin of hypericum perforatum l., method for obtaining said oleoresin and the use thereof |
| 09/12/2001 | EP1132463A2 Cosmetic composition comprising an antagonist of the neuropeptide Y receptor |
| 09/12/2001 | EP1132396A1 Physiologically active peptides |
| 09/12/2001 | EP1132388A2 Hexahydropyrazolo[4,3-c]pyridine metabolites |
| 09/12/2001 | EP1132079A1 Washing composition for keratinic materials comprising a low-ethoxylated sorbitan ester |
| 09/12/2001 | EP1131445A1 Human phospholipases |
| 09/12/2001 | EP1131428A2 Immunoglobulin superfamily proteins |
| 09/12/2001 | EP1131350A1 Egf-like nucleic acids and polypeptides and uses thereof |
| 09/12/2001 | EP1131326A1 Phospholipid derivatives of non-steroidal anti-inflammatory drugs |
| 09/12/2001 | EP1131316A2 Improved chemical process and pharmaceutical formulation |
| 09/12/2001 | EP1131304A1 N- 4-(3-chloro-4-fluoro-phenylamino)-7-(3-morpholin-4-yl-propoxy)-quinazolin-6-yl]-acrylamide, an irreversible inhibitor of tyrosine kinases |
| 09/12/2001 | EP1131295A1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| 09/12/2001 | EP1131294A1 Quinoline derivatives as nk-2 and nk-3 receptor ligands |
| 09/12/2001 | EP1131291A1 4-aroyl-piperidin-ccr-3 receptor antagonists iii |
| 09/12/2001 | EP1131290A1 Piperidine ccr-3 receptor antagonists |
| 09/12/2001 | EP1131068A1 Compositions of and process for producing isotretinoin having low particle size |
| 09/12/2001 | EP1131065A2 Utilisation of dialkylfumarates |
| 09/12/2001 | EP1131039A2 Use of a substance binding with the peripheral benzodiazepin receptor for treating skin stress |
| 09/12/2001 | EP1130964A1 Therapeutic anti-fungal nail preparation |
| 09/12/2001 | EP0991423B1 Topical treatment of psoriasis using neutralizing antibodies to il-8 |
| 09/12/2001 | EP0817775B1 Quinazoline derivatives |
| 09/12/2001 | EP0697885B1 Insulin-like growth factor ii as antitumour agent |
| 09/12/2001 | EP0682514B1 Use of topical anesthetics for the manufacture of a medicament for the treatment of bronchial asthma |
| 09/12/2001 | CN1312810A Substituted 1,8-naphthyridin-4(1H)-ones as phosphodiesterase 4 inhibitors |
| 09/12/2001 | CN1312719A Pharmaceutical Composition |
| 09/12/2001 | CN1312254A Novel nucleoside |
| 09/12/2001 | CN1312115A Apoplexy treating capsule and its preparation method |
| 09/12/2001 | CN1312106A Medicated wine for treating traumatic injury and its preparation method |
| 09/12/2001 | CN1312105A External-use liposome prepn for treating mite-borne dermatosis |
| 09/12/2001 | CN1312086A Medicine for treating acne and traumatic injury |
| 09/12/2001 | CN1312085A Dermatosis treating medicine |
| 09/12/2001 | CN1312082A Leukoderma curing plaster |
| 09/12/2001 | CN1312081A Wart and mole eliminating agent |
| 09/12/2001 | CN1312078A Making process of compound sulfadiazine zinc spreader |
| 09/12/2001 | CN1312076A External-use and eye ofloxacin zinc preparation |
| 09/12/2001 | CN1312065A Use of compound for improving skin and its mucous membrane physical-chemical property to prevent adsorption of microorganism |
| 09/12/2001 | CN1070708C Medicine for regrowing of muscle around exposed bone and preparing method thereof |
| 09/12/2001 | CN1070702C Use of 2,4-diamino pyrimidine 3-oxide or its salt thereof for treating collegen maturation and structuring disorders |
| 09/12/2001 | CN1070699C Topical composition comprising N-acetye-L-cysteine |
| 09/11/2001 | US6288278 Benzene derived amino alcohols as drugs |
| 09/11/2001 | US6288277 Drugs, antiarthritic agants, antihistamines for treatment of asthma |
| 09/11/2001 | US6288115 Use of zinc salts of conjugated linoleic acids to treat skin disorders |
| 09/11/2001 | US6288112 Use of pyrethroid compounds to promote hair growth |
| 09/11/2001 | US6288110 Pharmaceutical compositions comprising disulfiram |
| 09/11/2001 | US6288084 Administering comounds such as 4-(4-chlorophenyl)-1-(4-(3-methoxyphenyl)-4-(3-pyridinyl)-3 -butenyl)piperidin-4-ol to treat diseases associated with aberrant leukocyte recruitment and/or activation |
| 09/11/2001 | US6288083 Chemokine receptor antagonists and methods of use therefor |
| 09/11/2001 | US6288078 6-azaindole compounds as antagonists of gonadotropin releasing hormone |
| 09/11/2001 | US6288055 Analgesic agents |
| 09/11/2001 | US6288047 Lipid-based immune modulator composition |
| 09/11/2001 | US6288036 Bradykinin type peptides |
| 09/11/2001 | US6288025 Protease inhibitors for use in the treatment of psoriasis |
| 09/11/2001 | US6288024 Methods and compositions for inhibiting angiogenesis |
| 09/11/2001 | US6287786 Nucleic acid molecules encoding a new mammalian protein and to the use of these molecules in the characterization, diagnosis, and treatment of conditions such as disorders associated with cell proliferation, lipid metabolism and transport. |
| 09/11/2001 | US6287585 Microbiocides |
| 09/11/2001 | US6287579 Oxidatively stable long-chain ethyl ester emollients |
| 09/11/2001 | US6287576 Biostimulating agent |
| 09/11/2001 | US6287575 Vaccine against papillomatous digital dermatitis (PDD) |
| 09/11/2001 | US6287553 Skin care composition |
| 09/11/2001 | CA2230936C 5-azabicyclo(3.1.0)hexylalkyl-2-piperidones and -glutarimides as neurokinin receptor antagonists |
| 09/11/2001 | CA2208960C Hydroxyproline-rich proteins and pharmaceutical and cosmetic formulations containing them |
| 09/11/2001 | CA2018824C Use of kojic acid for treating pigmentation diseases |
| 09/09/2001 | CA2575854A1 Hexahydropyrazolo[4,3-c]pyridine metabolites |
| 09/07/2001 | WO2001064907A2 Lipid metabolism enzymes |
| 09/07/2001 | WO2001064756A1 Salmon-origin chondroitin sulfate |
| 09/07/2001 | WO2001064754A1 Gene recombinant antibody and its fragment |
| 09/07/2001 | WO2001064750A2 Modulation of the activity of the endothelial cel surface receptor ecrtp/dep-1 in the regulation of angiogenesis |
| 09/07/2001 | WO2001064749A2 Method for preparing anti-mif antibodies |
| 09/07/2001 | WO2001064691A1 Il-8 receptor antagonists |
| 09/07/2001 | WO2001064681A2 3-(pyrolyllactone)-2-indolinone compounds as kinase inhibitors |
| 09/07/2001 | WO2001064679A1 1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases |
| 09/07/2001 | WO2001064673A1 Flavone derivatives, preparation method and use as medicines |
| 09/07/2001 | WO2001064669A1 Pyrazole ether derivatives as anti-inflammatory/analgesic agents |
| 09/07/2001 | WO2001064666A1 Oxygen-containing heterocyclic compounds |
| 09/07/2001 | WO2001064655A1 2, 4-di(hetero-)arylamino (-oxy)-5-substituted pyrimidines as antineoplastic agents |
| 09/07/2001 | WO2001064653A1 Pyrimidine compounds |
| 09/07/2001 | WO2001064639A2 Pde iv inhibiting amides, compositions and pharmaceutical use |
| 09/07/2001 | WO2001064258A1 Agent for the treatment of wounds |
| 09/07/2001 | WO2001064249A1 Tissue decomposition inhibitor |
| 09/07/2001 | WO2001064225A1 Carbohydrate formulation (prebiotic adjuvant) for enhancement of immune response |
| 09/07/2001 | WO2001064214A2 Compositions and methods for the treatment of inflammatory diseases using topoisomerase inhibitors |
| 09/07/2001 | WO2001064208A1 Il-8 receptor antagonists |
| 09/07/2001 | WO2001064206A2 Inhibitors of melanocyte tyrosinase as topical skin lighteners |
| 09/07/2001 | WO2001064165A2 Il-8 receptor antagonists |
| 09/07/2001 | WO2001064046A2 Method for isolating sponge collagen and producing nanoparticulate collagen, and the use thereof |
| 09/07/2001 | WO2001064034A1 Antimicrobial sanitizing lotion with skin protection properties |
| 09/07/2001 | WO2001064031A2 Slpi knockout mice and methods for wound treatment |
| 09/07/2001 | WO2001034115A3 Method for encapsulating proteins or peptides in liposomes, liposomes produced using said method, and their use |
| 09/07/2001 | WO2001022923A3 Scar treatment composition |
| 09/07/2001 | WO2001021761A3 Recombinant adenoviral vectors and their utility in the treatment of various types of fibrosis: hepatic, renal, pulmonary, as well as hypertrophic scars |
| 09/07/2001 | WO2001019823A3 Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity |
| 09/07/2001 | WO2001016289A3 Zymogen activation system |
| 09/07/2001 | WO2001016135A3 Reverse-turn mimetics and methods relating thereto |